Home » Authors » Kim Coghill

Kim Coghill

Articles

ARTICLES

DiaDexus, Medarex Add Three Oncology Targets To Old Deal

Sep. 17, 2004

DiaDexus, Medarex Add Three Oncology Targets To Old Deal

Sep. 17, 2004

FDA Panel Wants 'Black Box' Warnings On Antidepressants

Sep. 16, 2004

FDA Panel Wants 'Black Box' Warnings On Antidepressants

Sep. 16, 2004

FDA, Industry Ask What Makes Biogenerics Work?

Sep. 15, 2004

FDA, Industry Ask What Makes Biogenerics Work?

Sep. 15, 2004

FDA Panel Evaluates SSRIs, Risk Of Suicidal Thoughts

Sep. 14, 2004

FDA Panel Evaluates SSRIs, Risk Of Suicidal Thoughts

Sep. 14, 2004

NIH To Make Federally Funded Research Available To Public

Sep. 13, 2004

NIH To Make Federally Funded Research Available To Public

Sep. 13, 2004

View All Articles by Kim Coghill

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 27, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 27, 2024.
In muscular dystrophies, gene therapies race the clock
BioWorld
Since the isolation of the gene that causes Duchenne muscular dystrophy (DMD), scientists have progressed in understanding the mechanisms that lead to muscular...
Bridgebio, with FDA approval, faces Pfizer in ATTR
BioWorld
With the U.S. FDA approval of Attruby (acoramidis) for transthyretin amyloidosis with cardiomyopathy (ATTR-CM), Bridgebio Pharma Inc. is taking on an industry...
‘Evo’ AI can design complete genomes
BioWorld Science
The development of new machine learning tools like Alphafold and Rfdiffusion has allowed scientists to predict the structure of proteins and design them for drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.